SARS-CoV-2疫情期间美国头颈肿瘤及微血管外科早期实践模式
该研究通过14家美国机构共享表格实时收集2020年3月27日至4月5日头颈外科实践数据。结果显示所有机构显著限制头颈肿瘤门诊评估,2家停止游离皮瓣手术,其余经委员会审查安排手术;临床量下降因素包括缺乏个人防护装备(35%)和缺乏快速COVID-19检测(86%)。结论认为快速检测对恢复头颈癌诊疗至关重要。
要点
- 疫情期间所有机构显著限制头颈肿瘤门诊评估。
- 2家机构停止游离皮瓣手术,其余经委员会审查安排手术。
- 86%机构缺乏快速COVID-19检测,35%缺乏个人防护装备。
核心结论
- COVID-19大流行导致头颈癌诊疗减少,快速COVID-19检测及与感染潜力的关联对恢复诊疗至关重要。
研究设计与样本
- 来自美国14家机构的头颈外科医生定期向共享表格贡献实践模式,分析2020年3月27日至2020年4月5日的数据。
主要发现
- 所有机构均显著限制头颈癌门诊评估。
- 2家机构停止游离皮瓣手术,其余机构通过委员会审查安排手术。
- 临床量减少的因素包括缺乏个人防护装备(35%)和缺乏快速COVID-19检测(86%)。
临床怎么用
- 快速COVID-19检测和评估感染潜力是恢复头颈癌患者诊疗的关键。
- 基于云端的实践模式共享平台在大流行演变中将至关重要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The SARS-CoV-2 (COVID-19) pandemic has caused rapid changes in head and neck cancer (HNC) care. "Real-time" methods to monitor practice patterns can optimize provider safety and patient care. METHODS: Head and neck surgeons from 14 institutions in the United States regularly contributed their practice patterns to a shared spreadsheet. Data from 27 March 2020 to 5 April 2020 was analyzed. RESULTS: All institutions had significantly restricted HNC clinic evaluations. Two institutions stopped free-flap surgery with the remaining scheduling surgery by committee review. Factors contributing to reduced clinical volume included lack of personal protective equipment (PPE) (35%) and lack of rapid COVID-19 testing (86%). CONCLUSIONS: The COVID-19 pandemic has caused a reduction in HNC care. Rapid COVID-19 testing and correlation with infectious potential remain paramount to resuming the care of patients with head and neck cancer. Cloud-based platforms to share practice patterns will be essential as the pandemic evolves.
引用
- Patel RJ, Kejner A, McMullen C, et al. Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic. Head Neck. 2020. PMID: 32329923. doi:10.1002/hed.26189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。